TheraRadar
← Back
Data updated: Mar 29, 2026

PIERRE FABRE

OncologyImmunologyGastroenterology
Specialty

PIERRE FABRE is a specialty pharmaceutical company focused on Oncology, Immunology, Gastroenterology.

1994
Since
2
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 90%
1 drugs Phase 3: 1 Phase 2: 4 Phase 1: 9
Immunology 7%
0 drugs Phase 2: 1
Gastroenterology 3%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology
Gilead Sciences biotech
Oncology, Immunology, Gastroenterology
ASTELLAS specialty
Oncology, Gastroenterology, Immunology